
EU competition enforcers have extended a near two-year investigation into Hungarian State aid for South Korean manufacturer Samsung electric vehicle (EV) battery factory after Hungary submitted new data to back its case.
Samsung SDI, an affiliate of South Korean tech giant Samsung Electronics, began production at the Hungarian plant in 2018, reported Reuters.
The European Commission opened an investigation in October 2019 to assess whether Hungary’s plans to grant €108 million (US$128.5 million) in State aid complied with the bloc’s competition rules.
“Hungary now argues that Samsung could have benefited from an investment grant and a tax exemption in an alternative location outside the EU, which would have increased the viability of the alternative location with respect to Hungary,” the Commission stated.
It stated that Budapest has also produced new documentary evidence to show that Samsung’s search for a location for the plant had also included a number of new production facilities in Europe and an alternative location in a less developed region in the EU.
Extending the EU investigation will allow third parties to comment on the Hungarian aid.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas